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STAT3 Is a Negative Regulator
of Granulopoiesis but Is Not Required
for G-CSF-Dependent Differentiation
sites on receptor cytoplasmic tails. Activation of the PI3
kinase pathway through recruitment of adaptor proteins
such as GAB2, SHP2, or Grb2 contributes to cell survival
(Hibi and Hirano, 2000), while the Ras-MAP kinase cas-
cade is activated during cell proliferation (Ihle, 1996).
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Selective mutagenesis of receptor signaling motifs
coupled with ectopic expression of dominant-negativeSummary
signaling molecules has been used to dissect the indi-
vidual requirements of distinct pathways in cell re-STAT3 has been described as an essential component
sponses. However, results of such studies have beenof G-CSF-driven cell proliferation and granulopoiesis.
contradictory and controversial. A case in point is analy-This notion was tested by conditional gene ablation
sis of the role of STAT3 during response of cells to G-CSF,in transgenic mice. Contrary to expectation, granulo-
a growth factor critical for granulopoiesis (Smithgall etcytes developed from STAT3 null bone marrow pro-
al., 2000). Early work using G-CSF-responsive cell linesgenitors, and STAT3 null neutrophils displayed mature
demonstrated potent activation of STAT3 as well aseffector functions. Rather than a deficit in granulo-
weaker activation of STAT1 and STAT5 (Tidow andpoiesis, mice lacking STAT3 in their hematopoietic
Welte, 1997). However, activation of STAT3 was linkedprogenitors developed neutrophilia, and bone marrow
to both proliferation and terminal differentiation and ar-cells were hyperresponsive to G-CSF stimulation.
rest of granulocytes, possibly reflecting cell type-spe-These studies provide direct evidence for STAT3-inde-
cific differences among the cell lines tested (Coffer etpendent granulopoiesis and suggest that STAT3 di-
al., 2000; Takeda and Akira, 2000). Analysis in transgenicrects a negative feedback loop necessary for control-
mice held out the prospect of precise definition of the
ling neutrophil numbers, possibly through induced
role of individual STAT proteins in cytokine responses.
expression of the signaling inhibitor, SOCS3.
Unlike other STAT proteins, none of which is required
for viability, ablation of STAT3 produced early embry-
Introduction onic lethality (Takeda et al., 1997). In fact, STAT3 is
required for maintenance of embryonic stem cells, at
Mammalian hematopoiesis follows an orchestrated pro- least in vitro (Boeuf et al., 1997; Matsuda et al., 1999;
gram of cell proliferation, differentiation, and apoptosis, Niwa et al., 1998; Raz et al., 1999), suggesting that it
resulting in expansion of progenitor stem cells that be- might be generally required for cell proliferation or sur-
come progressively restricted along distinct develop- vival. G-CSF plays a critical role in granulopoiesis in
mental lineages. The signals that control these steps vivo, as demonstrated by severe neutropenia in animals
remain poorly understood, but cytokines have been im- lacking the gene for G-CSF or for G-CSFR (Lieschke et
plicated in many aspects of this process, including as al., 1994; Liu et al., 1996). Moreover, it was recently
mitogens, survival factors, inducers of differentiation, reported that ablation of the STAT3 recruitment site on
and stimulators of cell migration and effector functions. the G-CSFR or ectopic expression of DN-STAT3 led to
Cytokines function through specific cell surface recep- a similar neutropenic phenotype, suggesting STAT3 is
tors that stimulate multiple intracellular signaling path- a major target for G-CSFR signaling (McLemore et al.,
ways, largely through activation of receptor-associated 2001). However, selective ablation of STAT3 expression
and cytoplasmic protein kinases (Ihle et al., 1995). in committed myeloid cells through Cre recombinase-
At least four signaling pathways contribute to cytokine dependent gene deletion directed by the macrophage
lysozyme promoter did not prevent normal productionaction. All of these pathways require activation of protein
of neutrophils (Takeda et al., 1999), limiting any STAT3tyrosine kinases of the JAK family and depend at least
requirement to an earlier, progenitor stage.in part on phosphorylation of specific tyrosine docking
We have examined the role of STAT3 in hematopoiesis
by selective ablation of the STAT3 gene in hematopoietic4 Correspondence: levyd01@med.nyu.edu
progenitor cells. In contrast to an expected neutropenic5 These authors contributed equally to this work.
phenotype, these mice produced excess neutrophils in6 Present address: Graduate Institute of Immunology, National Tai-
wan University Medical College, Taipei, Taiwan. both bone marrow and the periphery. STAT3 null pro-
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assay of total bone marrow cells of poly(I:C)-treated
mice showed efficient loss of the STAT3-flox allele and
creation of a novel, ablated STAT3 null allele (STAT3,
lanes 1 and 2). Similar treatment of STAT3f/f mice lacking
the Mx-Cre transgene showed no change in the struc-
ture of the STAT3 gene (lanes 3 and 4). Only trace
amounts of STAT3-flox were detectable following Mx-
Cre induction. Quantitation of the comparative levels of
STAT3 null to STAT3-flox indicated that the efficiency
of STAT3 deletion after poly(I:C) treatment was 95%
in the marrow (data not shown). Deletion of STAT3 by
poly(I:C) was also observed in other organs, with highest
efficiency in liver (100%), moderate efficiency in kid-
ney, spleen, lung, and heart (40%–60%), and lower effi-
ciency in skeletal muscle and testis (10%–20%) (data
not shown). For experiments in this paper, comparisons
were made between littermate STAT3f/f mice with or
without the Mx-Cre transgene, treated equivalently with
poly(I:C). STAT3/f heterozygous mice containing Mx-
Cre responded to poly(I:C) in a manner similar to that
of Cre-negative mice (data not shown), demonstrating
that the phenotypes observed were not due to expres-
sion of Cre or presence of the transgene but rather to
loss of STAT3. While adverse effects of Cre expression
have been noted in experiments with fibroblasts (Silver
and Livingston, 2001), hematopoietic cells do not appear
to be affected (de Alboran et al., 2001).
To further confirm a functional deletion of STAT3 inFigure 1. STAT3 Is Deleted in Bone Marrow
bone marrow from Mx-Cre animals, nuclear extracts pre-(A) Mx-Cre:STAT3f/f (Cre) or STAT3f/f mice were sacrificed 10 days
after poly(I:C) treatment. DNA from BM was analyzed for STAT3 by pared from poly(I:C)-treated, G-CSF-stimulated bone mar-
PCR (upper left panel). BM cells were stimulated with G-CSF (10 row cells were subjected to gel mobility shift analysis
ng/ml), and protein extracts were analyzed by EMSA (lower left) and in the absence or presence of anti-STAT antibodies. As
by immunoblotting with antibodies against phospho-STAT3, STAT3, shown in Figure 1A (lower left panel), a G-CSF-inducible
and STAT1, as indicated (right panel). ns, nonspecific.
protein-DNA complex, which was absent in cells from(B) Increased late-stage neutrophils in BM lacking STAT3. Neutrophil
Mx-Cre animals treated with poly(I:C), was detected inlineage cells were enumerated from control and STAT3KO marrow
extracts from control cells. This complex containedfollowing Wright-Giemsa staining.
STAT3 as indicated by reactivity with anti-STAT3 anti-
bodies but not anti-STAT1 antibodies, consistent with
genitors differentiated normally in response to G-CSF previous reports that STAT3 is the principal STAT acti-
and produced neutrophils that were morphologically vated in response to G-CSF. Significantly, no STAT3-
and functionally mature. These data demonstrate that DNA complex was detected in extracts from G-CSF-
STAT3 is not required for G-CSF-dependent prolifera- treated cells isolated from Mx-Cre mice, confirming loss
tion, differentiation, or survival of neutrophils. Instead, of STAT3. A similar conclusion was supported by West-
STAT3 is necessary for a negative feedback loop that ern blotting. STAT3 protein and tyrosine-phosphory-
controls neutrophil numbers. lated STAT3, a signature for activation, were readily de-
tected in STAT3f/f cells, but no signal was detected in
Results cells from Mx-Cre:STAT3f/f animals (Figure 1A, right
panel). Antibodies that recognized either N-terminal or
Generation of Mice Lacking STAT3 C-terminal regions of STAT3 that were not deleted in
in Hematopoietic Progenitors the mutant allele failed to detect STAT3 in mutant cells,
To overcome the STAT3 requirement during embryogen- showing that no cryptic product was expressed from
esis, we created conditionally mutant mice by using the the targeted allele. In particular, no immunoreactive pro-
loxP-Cre recombinase system (Zou et al., 1994). Mice tein of a size consistent with the targeted deletion (57
were created carrying a conditional STAT3 allele with kDa) was detected using antibodies directed against
exons 16–21 flanked by loxP sites (STAT3-flox), thus nondeleted regions. STAT1 and STAT1 proteins were
targeting critical portions of the STAT3 DNA binding and detected at equal levels in cells of both genotypes, dem-
SH2 domains for Cre-mediated excision to functionally onstrating the specificity of the disruption of STAT3.
ablate both STAT3and STAT3 (Raz et al., 1999). These These results demonstrated that deletion of STAT3 DNA
mice were mated with a transgenic line bearing Cre in Mx-Cre animals effectively ablated STAT3 protein in
recombinase driven by the IFN-inducible Mx promoter the marrow.
(Kuhn et al., 1995). Induction of Cre expression following
injection of the IFN-inducer poly(I:C) or of recombinant Granulopoiesis in the Absence of STAT3
IFN led to effective deletion of STAT3 gene segments To examine the consequence of STAT3 loss in Mx-
Cre:STAT3f/f mice, peripheral white blood cells were pre-in bone marrow (Figure 1A). A PCR-based genotyping
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Table 1. WBC Differential Count and Hematological Parameters
WBC Differential Count Control STAT3KO
Neutrophils (%) 11  4 69  12
Lymphocytes (%) 85  4 28  12
Macrophages (%) N.D. 2.7  1
Eosinophils (%) 4  0 N.D.
Hematological Parameters
Hematocrit (%) 54  0 54  2
Hemoglobin (g/dl) 15.2  0.7 15  0.8
Total WBC ( 103/	l) 6.5  0.7 7.2  0.7
Platelets ( 106/	l) 1.2  0 1.6  0.2
Peripheral blood from STAT3f/f (control) and Mx-Cre:STAT3f/f mice
(STAT3KO) treated with poly(I:C) was analyzed by Wright-Giemsa
staining and enumerated for granulocyte cell types and various he-
matological parameters, by standard methods. N.D., not detected.
pared for Wright-Giemsa staining 3 weeks after induced
deletion of STAT3. Morphologically identifiable neutro-
phils, lymphocytes, and myeloid cells were detected
in both mutant and control animals (Table 1). Normal
numbers of mature red blood cells were also detected
(data not shown). In contrast to animals lacking G-CSF
or G-CSFR that displayed a decrease in peripheral neu-
trophils (Lieschke et al., 1994; Liu et al., 1996), an in-
creased percentage of neutrophils and a corresponding
decreased percentage of lymphocytes were detected
in STAT3 mutant mice relative to controls. Increased
neutrophils were not likely due to an overt inflammatory
Figure 2. Peripheral Neutrophils Lacking STAT3 Are Functional
response because the total white blood cell count was
(A) In vitro differentiated granulocytes were stained with Giemsa
comparable between control and mutant mice and (upper panels) or for myeloperoxidase (lower panels).
would be expected to increase during infection (Table (B) Peritoneal exudate cells from thioglycollate-treated mice were
1). Moreover, animals were maintained on antibiotic analyzed for oxidation of dihydrorhodamine by FACS with or without
treatment with PMA. Mean fluorescence intensities and stimulationthroughout these experiments to suppress infections
index (S.I.) are indicated.that could complicate the analysis. Neutrophils were
(C) STAT3-deficient neutrophils are phagocytic. CFSE-labeled bac-also detected in spleen where a similar phenomenon of
teria were incubated with peritoneal neutrophils at 37
C for 30 min
a 4-fold increase in neutrophil numbers was detected (T  0), and gentamycin was added for another 30 min (T  30 min).
in mutant mice relative to controls (data not shown). Cells washed free of extracellular bacteria at T0 or T30 were analyzed
by FACS for engulfed bacteria.
(D) STAT3-deficient neutrophils are bactericidal. Bacteria engulfedSTAT3-Deficient Neutrophils Mature Normally
by neutrophils were enumerated by serial dilution.and Are Functional
Granulopoiesis in the absence of G-CSF or G-CSFR, in
the presence of a mutant G-CSFR unable to activate phil differentiation, and cell surface expression of these
proteins was enhanced by stimulation with PMA (dataSTAT3, or in the presence of dominant-negative STAT3
resulted in a profound neutropenia accompanied by ac- not shown).
Functional competence of STAT3-deficient neutro-cumulation of immature precursors (Lieschke et al., 1994;
Liu et al., 1996; McLemore et al., 2001). In contrast, an phils was confirmed by four different assays: differentia-
tion marker staining, respiratory burst, phagocytosis,excess of morphologically mature neutrophils was pres-
ent in the periphery of STAT3 null animals. Also in con- and bacterial killing. Bone marrow of control or mutant
mice was differentiated in vitro with G-CSF for 1 weektrast to the results observed in G-CSF or G-CSFR mutant
animals, no significant increase in precursors or imma- followed by staining with Giemsa and myeloperoxidase;
control and mutant neutrophils were comparable (Figureture granulocytes was detected in STAT3 null bone mar-
row. Rather, increased numbers of relatively mature band 2A). When neutrophils are exposed to appropriate stim-
uli, NADPH oxidase is activated, resulting in the con-and segmented stage PMN were observed (Figure 1B).
To further examine functional parameters of STAT3 sumption of oxygen and its conversion to superoxide
in a respiratory burst. Production of reactive oxygenmutant neutrophils, the ability of these cells to emigrate
to the peritoneal cavity was measured in response to intermediates was measured in peritoneal and periph-
eral blood neutrophils by oxidation of dihydrorhodaminethioglycollate (TGA). STAT3 mutant neutrophils traf-
ficked normally to the peritoneum, with 4- to 8-fold to fluorescent rhodamine following stimulation with
PMA. Neutrophils from both control and STAT3 null micegreater numbers accumulating within 4 hr compared to
control animals. TGA-elicited neutrophils stained nor- displayed an equivalent oxidative burst (Figure 2B). A
similar equivalence of respiratory burst potential wasmally for Gr-1 and CD11b, late-stage markers of neutro-
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observed using wild-type and mutant peripheral blood
(data not shown).
Neutrophils are phagocytic and bactericidal. To ex-
amine these parameters, carboxyfluorescein succinimi-
dyl ester (CFSE)-labeled bacteria were incubated with
TGA-elicited peritoneal granulocytes, and bacterial up-
take was monitored by FACS (Figure 2C). Bacterial up-
take was monitored before (T  0) and after a further
incubation with antibiotic to kill noninternalized bacteria
(T 30). Both wild-type and STAT3 null cells were capa-
ble of engulfing bacteria, although the STAT3-deficient
cells displayed a 30%–50% reduced phagocytic activity.
Bacterial killing was measured by determining the viabil-
ity of engulfed bacteria following lysis of bacteria-loaded
neutrophils (Figure 2D). Despite the reduction in phago-
cytic activity observed in STAT3 null neutrophils, bacte-
ria that were engulfed were effectively killed during a
30 min incubation. Taken together, the results show that
STAT3 null neutrophils are functional.
Normal Granulocyte Precursor Frequency
in the Absence of STAT3
Myeloid cells are derived from bone marrow progenitors,
and granulocytic differentiation is potentiated by G-CSF.
Granulocyte precursor frequencies were assessed in the
absence of STAT3 by colony formation assays. Bone
marrow from poly(I:C) treated control or Mx-Cre mice
was seeded in semisolid medium containing a cocktail
of IL-3, SCF, IL-6, and EPO (complete medium), support-
ing growth of a panoply of myeloid progenitors. Alterna-
tively, cells were cultured with G-CSF as the only sup-
portive cytokine to enumerate granulocyte precursors.
A comparable number of colonies formed from bone Figure 3. Normal Numbers of Granulocyte Precursors in the Ab-
marrow cells of both control and STAT3 mutant mice in sence of STAT3
complete medium (Figure 3A, left panel) and produced Control and STAT3KO BM were analyzed for myeloid precursors by
colony formation in methylcellulose.a mixture of mature cell types (right panel), including
(A) Colonies developed in complete medium (MethoCult M3434)morphologically mature neutrophils (arrows). Similarly,
containing SCF, IL-3, IL-6, and EPO. Example colonies of CFU-medium containing only G-CSF supported increased
GEMM are shown, and mature neutrophils are indicated by arrows.
colony numbers in a dose-dependent manner from bone (B) Colonies developed in the presence of G-CSF as the only sup-
marrow of both genotypes (Figure 3B, left panel), dem- porting cytokine.
onstrating equal numbers of general precursors and of (C) Individual colonies developed in complete medium (left panel)
or in response to G-CSF (right panel) were genotyped for STAT3.granulocyte precursors despite loss of STAT3. Similar
A heterozygous flox/ sample was included for comparison. ns,to the result with cells matured in response to complete
nonspecific.medium, cells with typical mature neutrophil morphol-
ogy developed in response to G-CSF, regardless of
STAT3 status (right panel). creased abundance of neutrophils in the periphery could
Since poly(I:C)-induced deletion may not be 100%, we be due to increased proliferation. G-CSF is known to
tested whether cytokine-dependent colony formation increase production and release of neutrophils from
favored selective outgrowth of residual wild-type cells bone marrow, and it is widely used to treat neutropenia
from mutant marrow. PCR assays performed on isolated in clinical settings. To directly investigate possible roles
individual colonies verified the presence of cells with for STAT3 in G-CSF action in vivo, an experimental auto-
the expected genotypes (Figure 3C). Colonies devel- reconstitution assay was used to monitor newly formed
oped from control marrow carried the STAT3-flox allele bone marrow granulocytes and release of peripheral
while Mx-Cre:STAT3-flox marrow produced only STAT3 neutrophils. Mice were deleted for STAT3 by two doses
null colonies. These data confirm that G-CSF-dependent of poly(I:C) treatment, and their marrow was ablated by
granulopoiesis is not impaired in the absence of STAT3, treatment with 5-fluorouracil. Subsequent hematopoi-
but the neutrophilia observed in STAT3 null animals can- etic repopulation was followed in mice with or without
not be explained by increased progenitor frequency. treatment with G-CSF. Peripheral blood Gr-1 leuko-
cytes from autoreconstituted mice were assayed for in-
tracellular STAT3 and quantified by FACS. Figure 4ASTAT3 Is Not Required for Response to G-CSF In Vivo,
but STAT3 Null Granulocytes Are Hyperproliferative shows results from a representative experiment in which
9% of peripheral blood cells were Gr-1 positive in aThe similar numbers of granulocytic progenitors de-
tected in STAT3 mutant marrow suggested that the in- STAT3f/f control animal, and that percentage increased
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row could be due to the cell-autonomous loss of STAT3
protein in progenitor cells or to alterations in the bone
marrow microenvironment, such as from altered cytokine
production. The cell-autonomous contribution of STAT3
to granulopoiesis was investigated by bone marrow trans-
plantation. Control and STAT3 null marrow were injected
intravenously into lethally irradiated wild-type recipi-
ents. Five weeks after transplantation, bone marrow,
peritoneal exudate, and peripheral organs were ana-
lyzed for granulocytes by FACS (Figure 4B). Gr-1 cells
developed from both wild-type and STAT3 null precur-
sors and were detected in both the marrow and the
periphery of recipients. The great majority of neutrophils
developing from STAT3 null donors lacked detectable
STAT3 protein, with the small number of STAT3-positive
cells being derived either from residual recipient-derived
cells due to incomplete irradiation or from the small
number of donor cells that did not undergo recombina-
tion. Consistent with the neutrophilia observed in Mx-
Cre mice, an increased percentage of granulocytes ac-
cumulated in the marrow of recipients reconstituted with
STAT3 null cells, and peripheral cells were morphologi-
cally mature (Figure 4C). The absence of STAT3 in the
reconstituted cells derived from mutant donors was con-
firmed by immunoblotting (Figure 4D). Increased neutro-
phils were also observed in spleen and peripheral blood
of mice transplanted with STAT3 null cells (data not
shown). These data conclusively demonstrate that
STAT3 is not required for the development of mature
neutrophils and that loss of STAT3 in hematopoietic
progenitors rather than in stromal tissue or other organs
contributes to increased granulopoiesis.
Enhanced Proliferation, Prolonged Signaling,
Figure 4. Enhanced Granulopoiesis In Vivo in the Absence of STAT3 and Reduced Induction of SOCS3 by G-CSF
(A) Hematopoiesis in the absence of STAT3. 5-Fluorouracil-treated in the Absence of STAT3
control and STAT3KO mice were treated with G-CSF or BSA (10 Proliferation of control and STAT3 null bone marrow
	g/kg) daily for 7 days. Peripheral blood from control (upper panel)
cells cultured in vitro was measured in response to in-or STAT3KO mice (lower panel) was analyzed by FACS for Gr-1 and
creasing amounts of G-CSF (Figure 5A, left panel) or ofSTAT3.
IL-3 (right panel). Proliferation of control bone marrow(B) BM transplantation. Donor BM from control or STAT3KO mice
was analyzed by FACS for Gr-1 and STAT3 prior to transplantation cells plateaued at approximately 1 ng/ml G-CSF while
(left panels). Five weeks after transplantation, peritoneal exudate proliferation of STAT3 null cells continued to increase
cells (PEC, middle panels) and BM cells (BM, right panels) were with increasing G-CSF. In contrast, control and STAT3
analyzed by FACS.
null cells responded similarly to IL-3. The increased pro-(C) PEC from recipient mice were stained with Wright-Giemsa.
liferation of mutant cells could not be accounted for by(D) Cell extracts from PEC and BM of recipient mice were immu-
decreased apoptosis, since no significant difference innoblotted for STAT3 and STAT1.
TUNEL-positive or Annexin V-positive cell numbers was
observed between control and STAT3 null cultures (data
not shown). Importantly, no decrease in cell proliferationapproximately 3-fold following G-CSF treatment. In con-
trast, the percentage of neutrophils in the periphery of was observed in the absence of STAT3 as would be
expected if it contributed an essential component toSTAT3-deficient mice was high even in the absence
of cytokine treatment and did not increase further in G-CSF-driven cell growth.
It must be noted that bone marrow cells from wild-response to exogenous G-CSF. The cells repopulating
mutant mice were not due to inefficient deletion of type and STAT3-ablated mice are not identical popula-
tions due to enhanced mutant granulopoiesis in vivo.STAT3 in response to poly(I:C), as indicated by loss
of intracellular STAT3 in mutant cells. The response to To determine whether enhanced response to G-CSF
was cell autonomous or reflected different starting cellG-CSF averaged 3-fold in control mice while no increase
in peripheral or bone marrow neutrophils was observed populations, we isolated immature granulocytes from
mice shortly after gene ablation in response to poly(I:C).in G-CSF-treated STAT3 null animals, although these
animals displayed a 3- to 4-fold higher granulocyte Following enrichment by density gradient for immature
cells, equivalent numbers of Gr-1/CD11b cells (Figureabundance despite whether or not they were treated
with G-CSF. 5B) were analyzed for proliferation. Similar to unfraction-
ated bone marrow, STAT3 null cells showed enhancedEnhanced granulopoiesis from STAT3 null bone mar-
Immunity
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Figure 6. G-CSF Stimulates Prolonged STAT1 Phosphorylation but
Impaired Gene Induction in STAT3 Null Cells
(A) BM cells were untreated or stimulated with 10 ng/ml G-CSF for
15 min, 1 hr, or 2 hr, or with 10 ng/ml IL-3 for 15 min and analyzed
for phospho-STATs and STAT1 levels, as indicated.
(B) Percoll-purified immature BM cells were stimulated with 10 ng/
ml G-CSF and analyzed for SOCS3, JunB, and -actin expression
by RT-PCR.
absence of STAT3, activation of different STAT proteins
was measured in response to G-CSF. Control cells dis-Figure 5. Enhanced G-CSF-Dependent Proliferation in the Absence
played transient and high level activation of phospho-of STAT3
STAT3, with lower levels of phospho-STAT1 and barely(A) Enhanced proliferation of STAT3 null BM in response to G-CSF
(left panel) but not to IL-3 (right panel). detectable levels of phospho-STAT5, a protein that was
(B) Comparable numbers of immature granulocytes were fraction- much more sensitive to IL-3 treatment (Figure 6A).
ated from BM of control and STAT3 null mice 4 days after poly(I:C) STAT3 null cells displayed essentially no phospho-
treatment. STAT3, while both STAT1 and STAT5 were still phos-
(C) Enhanced proliferation of STAT3 null immature granulocytes in
phorylated. Interestingly, significant phospho-STAT1response to G-CSF, as measured by 3 H-thymidine incorporation.
was observed even under basal conditions, and its(D) Dose-dependent enhancement of STAT3 null cell proliferation,
measured by BrdU incorporation into Gr-1 immature granulocytes. phosphorylation was more sustained, remaining signifi-
cantly elevated 2 hr after G-CSF stimulation. Altered
phosphorylation kinetics was not due to changes in
STAT1 abundance, which remained approximately equalproliferation in response to increasing G-CSF treatment
by both 3 H-thymidine incorporation (Figure 5C) and by between control and STAT3 null cells (Figure 6A). Phos-
phorylation levels of STAT5 were comparable, regard-BrdU incorporation into Gr-1 cells (Figure 5D).
We considered what might underlie the increased less of genotype.
Prolonged activation of STAT1 might reflect sustainedgranulocyte abundance in STAT3 null bone marrow and
the G-CSF-dependent proliferation of STAT3 null granu- signaling in response to G-CSF. Important feedback in-
hibitors of JAK catalytic activity in response to cytokineslocytes. One possibility might be increased expression
of G-CSF or G-CSF receptors. However, no significant are the SOCS proteins, and expression of SOCS3 is
significantly induced in response to G-CSF (Endo etdifferences in G-CSF or G-CSFR mRNA levels were de-
tected (data not shown). Alternatively, enhanced prolif- al., 1997; Naka et al., 1997; Starr et al., 1997). Once
expressed, SOCS3 is recruited to phosphorylated cyto-eration could be due to aberrant mitogenic signaling.
G-CSF is known to activate STAT1 and STAT5 in addition kine receptors and inhibits JAK catalytic activity (Krebs
and Hilton, 2001). As shown in Figure 6B, SOCS3 wasto STAT3, each of which might be involved in regulating
cell proliferation. To test for heightened signaling in the rapidly induced in G-CSF-treated control cells. By con-
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trast, induction of SOCS3 was impaired in the absence showed complete loss of STAT3 protein, and the bulk
of autoreconstituted or transplant-derived neutrophilsof STAT3. Similarly, induction of other STAT3-inducible
genes, such as JunB (Figure 6B) and FcRI (data not showed loss of STAT3 (Figure 4A). Finally, Western blot
analysis of elicited peritoneal exudate cells, which con-shown), was decreased in response to G-CSF, consis-
tent with the loss of STAT3. These results demonstrate sisted of highly enriched mature neutrophils, showed
no STAT3 (Figure 4D).that STAT3 is required for induction of SOCS3 in re-
sponse to G-CSF and suggest that absence of SOCS3 Another consideration is the distinct differences be-
tween previous studies implying a requirement for STAT3negative feedback may allow prolonged JAK catalytic
activity, resulting in enhanced signaling and heightened and the present gene-targeting approach. The mutant
G-CSF receptor unable to activate STAT3 (d715F) is alsoproliferation.
severely truncated in its cytoplasmic domain, possibly
complicating the phenotype of this mouse. In fact, theDiscussion
deleted G-CSFR induces a heightened proliferative re-
sponse to G-CSF, resulting in prolonged activation ofSTAT3 Is Dispensable for Granulocyte Proliferation
STAT1, STAT3, and STAT5 and impaired ligand-depen-and Differentiation
dent receptor downregulation (Hermans et al., 1998).Normal development of the granulocyte lineage requires
Similarly skewed responses have been observed withG-CSF signaling (Lieschke et al., 1994; Liu et al., 1997),
other mutant cytokine receptors. Forced expression ofand a major target of the G-CSFR is STAT3 (Figures
mutant gp130 proteins that contain only one of the criti-1A and 6A). Indeed, transgenic mice with a targeted
cal tyrosine residues normally found in its cytoplasmicmutation of G-CSF receptor (d715F) that abrogates
tail showed that different tyrosine residues contributeSTAT3 activation display severe neutropenia with an
distinct signals to IL-6-mediated responses. Moreover,accumulation of immature myeloid precursors in their
point mutant receptors behave differently from trun-bone marrow. Expression of a constitutively active ver-
cated mutant receptors (Schmitz et al., 2000). In thesion of STAT3 rescues this phenotype, a condition that
case of G-CSFR, the d715 receptor caused increasedcan also be mimicked by expression of a dominant-
proliferation in response to G-CSF. Mutation of its singlenegative form of STAT3 in wild-type mice. Such data
remaining tyrosine residue resulted in a loss of STAT5have led to the conclusion that STAT3 activation is re-
phosphorylation, in addition to STAT3 (McLemore et al.,quired for normal G-CSF-dependent proliferation and
2001). While STAT5 is not required for granulopoiesisgranulocyte differentiation (McLemore et al., 2001). In
or G-CSF-dependent proliferation (Teglund et al., 1998),this study, we have directly tested this notion through
loss of STAT5 phosphorylation by the d715F receptortargeted deletion of STAT3 in hematopoietic progenitor
indicates that this mutation cannot be considered spe-cells in the bone marrow of transgenic mice. In contrast
cific for STAT3. Consistent with this notion, it is probableto previously reported results, we detected no impair-
that impaired granulopoiesis observed in mice express-ment in granulocyte proliferation and terminal differenti-
ing a dominant-negative STAT3 could reflect crossinhi-ation in the absence of STAT3. Rather, evidence was
bition of other receptor-mediated signals beyond STAT3obtained that STAT3 is a negative regulator for G-CSF-
activation that depend on the same recruitment site.mediated proliferation and homeostasis of granulo-
Similar discrepancies between the effects of dominant-cytes. In the absence of STAT3, enhanced G-CSF-
negative STAT proteins and the corresponding null phe-dependent proliferation was observed in responsive
notypes have been reported (Ihle, 2001).progenitor cells, and mice lacking STAT3 in their hema-
topoietic precursors developed neutrophilia, as did wild-
type mice transplanted with STAT3 null progenitors. STAT3 as a Negative Regulator of
G-CSF-Mediated GranulopoiesisLoss of STAT3 affected neither the frequency of granulo-
cytic precursors nor their ability to differentiate into ma- The enhanced production of neutrophils in the absence
of STAT3 is reminiscent of the phenotype derived fromture, functional effector cells. STAT3 null granulocytes
displayed a respiratory oxidative burst, increased ex- the G-CSFR mutant found in human severe congenital
neutropenia (Hermans et al., 1998; McLemore et al.,pression of surface markers, and the ability to phagocy-
tose and kill bacteria. Therefore, STAT3 is dispensable 1998). The hypergranulopoiesis of mutant mice bearing
this receptor correlated with prolonged activation offor granulocyte proliferation, differentiation, and func-
tion but is required for homeostasis. STAT1, STAT3, and STAT5 in response to G-CSF treat-
ment (Hermans et al., 1999). Interestingly, prolongedSeveral possibilities may account for the discrepancy
between functional impairments of STAT3 studied pre- activation of STAT1 though not STAT5 was also ob-
served in the absence of STAT3 following G-CSF stimu-viously and the absence of STAT3 studied here. A trivial
explanation could be that our mice express a low but lation. However, a requirement for STAT1 in G-CSF-
mediated granulopoiesis is unlikely, given the normalsufficient level of STAT3. Although the deletion of STAT3
is not absolute in Mx-Cre mice, several lines of evidence proliferation, accumulation, and function of granulo-
cytes in STAT1-deficient mice (Durbin et al., 1996; Merazpreclude the possibility that mature neutrophils are de-
rived from residual STAT3-containing precursors. First, et al., 1996). Nonetheless, a critical interaction between
STAT1 and STAT3 in G-CSF-dependent granulopoiesislittle residual wild-type STAT3 allele was detected in
mutant bone marrow (Figure 1A), and individual G-CSF- cannot be excluded.
More likely, however, is that enhanced proliferationderived colonies from mutant progenitors demonstrated
complete absence of STAT3 (Figure 3C). Similarly, pro- of granulocytes in response to G-CSF and neutrophilia
observed in mutant mice resulted from loss of negativetein immunoblots and DNA binding assays consistently
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regulatory signals and that prolonged STAT1 activation devoid of intracellular tyrosines (Ward et al., 1999). In
contrast, activation of STAT3 by the truncated d715is a symptom of that impaired negative feedback. The
severe impairment of SOCS3 induction is consistent receptor is completely blocked by loss of the single
remaining tyrosine, even at high G-CSF concentrations.with this notion, since SOCS3 as an inducible suppres-
sor of cytokine signaling is normally responsible for inhi- These results suggest that emergency granulopoiesis in
response to high levels of G-CSF may be accomplishedbition of receptor-associated JAK catalytic function. The
promoter of SOCS3 contains a functional STAT3 binding through an independent signaling pathway mediated by
a non-phosphotyrosine-dependent mechanism involv-element that is critical for LIF-mediated induction
(Auernhammer et al., 1999). SOCS3 also negatively regu- ing the distal region of the G-CSFR. While STAT3 activa-
tion is a marker for both receptor tyrosine-dependentlates IL-6 signaling, and antagonism of SOCS3 function
can lead to development of colitis, due at least in part (low dose G-CSF) and receptor tyrosine-independent
(high dose G-CSF) signaling pathways, it appears to beto hyperactivity of cytokine signals that target STAT3
(Suzuki et al., 2001). dispensable for both mechanisms of granulopoiesis. In
fact, mice lacking STAT3 in the bone marrow developIt is interesting that a constitutively active form of
STAT3 partially rescued the ability of progenitor cells severe neutrophilia in response to bacterial infection
(data not shown).from d715F mice to differentiate into neutrophils in re-
sponse to G-CSF (McLemore et al., 2001). These data Emergency granulopoiesis can also be independent
of G-CSF, presumably through the action of other hema-could be interpreted as showing that STAT3 is capable
of driving G-CSF-dependent differentiation, even though topoietic cytokines. For instance, G-CSF-deficient mice
develop neutrophilia during Candida infections (Basu etSTAT3 deletion showed that it is not necessary. It must
be borne in mind, however, that the constitutively active al., 2000). Although IL-6 is an independent regulator of
granulopoiesis and is increased in the serum of Can-STAT3 protein also displays oncogenic properties
(Bromberg et al., 1999) and therefore cannot be consid- dida-infected, G-CSF-deficient mice, this cytokine was
also dispensable for the observed neutrophilia sinceered a faithful mimic of normal STAT3 function. In fact,
expression of constitutively active STAT3 in bone mar- neutrophilia developed in infected mice deficient for
both IL-6 and G-CSF (Basu et al., 2000). Although bothrow progenitors led to increased cell numbers as well
as increased differentiation (McLemore et al., 2001). In IL-6 and G-CSF are efficient activators of STAT3, it is
intriguing that neutrophilia can develop in the absencea similar fashion, constitutively active STAT5 is capable
of causing myeloproliferative disease (Schwaller et al., of all three of these molecules. It would be interesting
if emergency, G-CSF-independent granulopoiesis was2000), even though it is not required for normal myelo-
proliferation or differentiation (Teglund et al., 1998). It is somehow caused by antagonism of the normally inhibi-
tory function of STAT3, such as inhibition of SOCS pro-possible that STAT3 will be found to contribute to my-
eloid oncogenesis in spite of its dispensability for normal tein expression.
granulopoiesis.
Experimental ProceduresDue to alternative splicing, STAT3 is expressed as
two isoforms, STAT3 and STAT3 (Schaefer et al.,
Animals
1997), both of which were functionally ablated by our Generation of a conditional STAT3 allele in ES cells has been pre-
targeting strategy. STAT3 lacks a transactivation do- viously described (Raz et al., 1999). Mice were generated by injection
main and antagonizes the activity of STAT3. Indeed, of heterozygous targeted ES cells into blastocysts at the transgenic
mouse facility of Albert Einstein College of Medicine by standardrecent gene targeting of the STAT3 locus documented
methods. Interbreeding with transgenic Mx-Cre mice (Kuhn et al.,a critical role for this isoform in recovery from endotoxic
1995) generated littermate mice that were homozygous for the con-shock (Yoo et al., 2002), demonstrating its role as a
ditional STAT3 allele (STAT3f/f) with or without the Mx-Cre transgene.
negative regulator of gene expression. Therefore, it is Induction of Cre and subsequent deletion of STAT3 was accom-
possible that lack of STAT3 function contributes to the plished by two successive intraperitoneal injections separated by
loss of negative regulation responsible for the observed 7 days with 100 	g poly(I:C) per mouse (Radtke et al., 1999) unless
otherwise specified and comparisons were made between Mx-Cre-neutrophilia in STAT3 null mice. If so, STAT3 would be
positive and Mx-Cre-negative STAT3f/f littermates that had beena more general negative regulator than originally sug-
similarly treated with poly(I:C). Neomycin (2 mg/ml) was added togested, inhibiting gene expression beyond inhibition of
drinking water to eliminate bacterial infection and intestinal flora.
STAT3. All work with animals conformed to guidelines approved by the
Institutional Animal Care and Use Committee of the New York Uni-
versity School of Medicine.STAT3 and Emergency Granulopoiesis
Under certain stressful situations, such as response to
Hematologypathogen infection, rapid expansion of neutrophil popu-
Peripheral blood or in vitro differentiated bone marrow (BM) was
lations can be achieved through a process known as prepared by blood smear or cytospin centrifugation and stained
emergency granulopoiesis that is accompanied by high with Wright-Giemsa. Differential cell counts were scored visually on
levels of G-CSF (Basu et al., 2000; Lieschke et al., 1994; coded samples. For in vitro differentiation, BM collected from femurs
was cultured in RPMI-1640 medium containing 20% fetal bovineWard et al., 1999). Emergency granulopoiesis demon-
serum and 10 ng/ml recombinant murine G-CSF (PeproTech).strates some of the complexity of molecular responses
to G-CSF. For instance, STAT3 activation by G-CSFR
Autoreconstitution and Colony Formationcan be achieved through both receptor tyrosine-depen-
Age 6- to 8-week-old mice (five mice per group) were injected with
dent and -independent mechanisms, depending on 100 	g poly(I:C) on days 1 and 7. 5-Fluorouracil (300 mg/kg) was
G-CSF concentration. At saturating concentrations (100 injected on day 10 followed by subcutaneous injection of BSA or
G-CSF (10 	g/kg) daily for 7 days. BM cells were prepared 4 hr afterng/ml), STAT3 can be activated by a full-length G-CSFR
Neutrophil Development without STAT3
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the last injection. For colony formation assays, 4  104 BM cells Phagocytosis and Bactericidal Assays
Peritoneal granulocytes were harvested by lavage from thioglycol-were incubated in complete medium (MethoCult M3434, Stem Cell
Technology) containing 0.9% methylcellulose in Iscove’s modified late-treated mice, washed, and resuspended in medium containing
5% FCS and lacking antibiotics. Listeria monocytogenes labeledDulbecco’s media, 1% BSA, 104 M 2-mercaptoethanol, 2 mM
L-glutamine, 15% fetal bovine serum, 10 	g/ml bovine pancreatic with 5 	M CFSE was mixed with 2  106 peritoneal exudate cells
and incubated at 37
C for 30 min. Subsequently, extracellular bacte-insulin, 200 	g/ml human transferrin, 10 ng/ml recombinant murine
IL-3, 10 ng/ml recombinant human IL-6, 50 ng/ml recombinant mu- ria were killed by incubation with 50 	g/ml gentamycin. Phagocytic
activity was assessed by FACS on paraformaldehyde-fixed cells.rine stem cell factor, and 3 U/ml recombinant human EPO. For
granulocyte-specific colonies, 2  105 BM cells were incubated in To measure bactericidal activity, engulfed bacteria were released
by lysing eukaryotic cells in water, and surviving bacteria were enu-medium (MethoCult M3234) containing the same components ex-
cept with 1, 10, or 100 ng/ml of recombinant murine G-CSF as the merated by serial dilution.
only cytokine, followed by incubation for 7–10 days.
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